| Hazard Information | Back Directory | [Uses]
SARS-CoV-2 Mpro-IN-25 (Compound 3a) is a SARS-CoV-2 protease inhibitor with an IC50 value of 0.26 μM. SARS-CoV-2 Mpro-IN-25 exhibits antiviral activity and can be used in pneumonia-related research[1]. | [References]
[1] de Carvalho MAG, et al. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease. Arch Pharm (Weinheim). 2024 Aug 15:e2400253. DOI:10.1002/ardp.202400253 |
|
|